Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung TB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01785186
What this trial is testing

Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design

Who this might be right for
Tuberculosis, Pulmonary
Michael Hoelscher 365
Not applicableStudy completedNCT03909620
What this trial is testing

Utility of LDCT in Lung Cancer Screening in a TB Endemic Region

Who this might be right for
Lung Cancer
Post Graduate Institute of Medical Education and Research, Chandigarh 253
Not applicableUnknownNCT05017324
What this trial is testing

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

Who this might be right for
Rifampicin Resistant TuberculosisDrug-resistant TuberculosisMultidrug Resistant Tuberculosis+1 more
Universiteit Antwerpen 248
Not applicableStudy completedNCT00772408
What this trial is testing

Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis

Who this might be right for
Pulmonary TuberculosisGenetic Variants of HostImmune Response of Host
Chang Gung Memorial Hospital 300
Not applicableStudy completedNCT04048018
What this trial is testing

Performance Evaluation of the VIDAS TB-IGRA Assay.

Who this might be right for
Active TuberculosisLatent Tuberculosis InfectionNon-Tuberculous Mycobacterial (NTM) Pneumonia
BioMérieux 2,401
Testing effectiveness (Phase 2)Study completedNCT00760149
What this trial is testing

Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Radboud University Medical Center 150
Large-scale testing (Phase 3)Study completedNCT00341328
What this trial is testing

Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.

Who this might be right for
Tuberculosis
Ministry of Science and Technology, India 300
Testing effectiveness (Phase 2)Study completedNCT04179500
What this trial is testing

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 26
Not applicableUnknownNCT02653404
What this trial is testing

IGRA and Mantoux Response in Children With Suspected Latent or Active TB Infection

Who this might be right for
Tuberculosis, PulmonaryInterferon-gamma Release TestsTuberculin Test
University of Siena 50
Not applicableUnknownNCT04074369
What this trial is testing

Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects

Who this might be right for
Tuberculosis, Pulmonary
Huashan Hospital 800
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Not applicableUnknownNCT05526573
What this trial is testing

Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions

Who this might be right for
Lung CancerLung; NodeLung Diseases+3 more
Azienda Sanitaria-Universitaria Integrata di Udine 148
Testing effectiveness (Phase 2)Study completedNCT02371681
What this trial is testing

NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 262
Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Not applicableUnknownNCT06392594
What this trial is testing

Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis and Resistant Pulmonary TB

Who this might be right for
Tuberculosis, Pulmonary
Assiut University 46
Not applicableStudy completedNCT00865826
What this trial is testing

Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals

Who this might be right for
HIV InfectionsTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 801
Testing effectiveness (Phase 2)Study completedNCT03160638
What this trial is testing

Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
University Medical Center Groningen 24
Testing effectiveness (Phase 2)Study completedNCT02481726
What this trial is testing

68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT

Who this might be right for
Lung CancerLung Tuberculosis
Xijing Hospital 31
Not applicableStudy completedNCT03831906
What this trial is testing

Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)

Who this might be right for
TuberculosisSevere PneumoniaCovid19
Institut National de la Santé Et de la Recherche Médicale, France 2,570
Testing effectiveness (Phase 2)Study completedNCT00401271
What this trial is testing

Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Otsuka Frankfurt Research Institute GmbH 54
Next Page